Highlights Q-linea AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:31 2024-04-29 am EDT			5-day change	1st Jan Change
2.91 ^SEK	-11.68%		+39.90%	-21.35%

Mar. 13	Q-linea AB Presents Strong ASTar Results At AMCLI	CI
Feb. 27	Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024

Q-linea AB Presents Strong ASTar Results At AMCLI	Mar. 13	CI
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Q-linea Presents at AMCLI	Feb. 15	CI
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	Feb. 09	MT
Q-linea Lands First ASTar Order from Finnish Distributor	Jan. 31	MT
Q-Linea AB Receives an Order for an ASTar System	Jan. 31	CI
Q-linea AB Expands the Gram-Negative Panel	Jan. 17	CI
Q-Linea Wins Public Tender for Rapid AST	Jan. 15	CI
Q-linea Installs First ASTar Systems in US; Shares Jump	Dec. 28	MT
Q-linea Signs Distribution Deal for Benelux Region with Biomedical Diagnostics	Nov. 17	MT
Q-linea AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Sweden's Q-linea Partners with Labema to Boost Presence in Finland, Baltic States	23-10-19	MT
Q-Linea AB Strengthens its Presence in Finland and the Baltics Through Partnership with Labema Oy	23-10-19	CI
Q-linea AB Receives Second ASTar Order in France	23-09-28	CI
Q-linea Shares Gain Amid Progress of French Distribution Deal	23-07-27	MT
Q-linea AB Receives First ASTar Order in France	23-07-27	CI
Q-linea AB Completes its 510(k) Application for US Market Approval	23-07-17	CI
Q-linea AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-13	CI
Q-linea AB Announces First Patient Enrolls in Lifetimes	23-06-14	CI

No results for this search